Taro Pharmaceutical Industries Ltd.
(NYSE : TARO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
1.22%158.252.9%$705.46m
ZTSZoetis, Inc. Class A
1.35%125.351.9%$244.96m
MYLMylan N.V.
5.22%18.533.2%$193.76m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
3.73%6.392.0%$144.12m
TXMDTherapeuticsMD, Inc.
-3.70%2.8624.9%$10.87m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
1.03%35.252.0%$8.03m
TAROTaro Pharmaceutical Industries Ltd.
1.24%81.526.4%$3.46m
KINKindred Biosciences, Inc.
4.45%7.280.3%$1.76m
ABEOAbeona Therapeutics, Inc.
1.38%2.207.6%$1.52m
LFVNLifeVantage Corporation
-6.41%11.683.3%$1.06m
JAGXJaguar Animal Health, Inc.
-8.26%1.119.8%$0.59m
CPHIChina Pharma Holdings, Inc.
-1.12%0.260.1%$0.05m

Company Profile

Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.